Search results
PROMOTED
Stay up to date with the latest clinical evidence in transthyretin amyloid cardiomyopathy (ATTR-CM) with this video series spotlighting key cardiomyopathy updates presented at ESC Heart Failure Congress (HFA) 2026.In the first session, Dr Mathew Maurer (Columbia University, New York, US) takes a deep dive into the CARDIO-TTRansform data, exploring the current treatment landscape and ongoing unmet…
View more
Spotlight on HFA 2026: Updates on Cardiomyopathies
Added:
1 month ago
Video Series
Added:
3 weeks ago
MRA Use in Contemporary Heart Failure Care
Added:
2 days ago
Review Article
Added:
1 week ago
Dr Lin Yee Chen (University of Minnesota Medical School, Minneapolis, MN, US) joins us to examine which artificial intelligence (AI) applications in heart failure are ready for clinical use today, and which remain experimental. As AI moves from research settings into the clinic, separating genuine clinical utility from hype has become a pressing question for heart failure specialists.In this…
View more
Added:
1 week ago
Dr Robert J Mentz (Duke University Medical Center, Durham, NC, US) joins us to discuss decision-making in cardio-kidney-metabolic (CKM) disease, focusing on how to sequence and individualise guideline-directed therapy when heart failure, renal dysfunction and metabolic disease coexist.Dr Mentz examines how competing priorities — decongestion, blood pressure and renal function — shape the order in…
View more
Added:
1 week ago
Prof Isabella Kardys (Erasmus MC University Medical Center, Rotterdam, NL) joins us to discuss how proteomic phenotyping, serial biomarkers and digital monitoring could enable more personalised, proactive heart failure care.Prof Kardys outlines work applying large-scale proteomics to HFpEF, where serial profiling of around 5,000 proteins in over 400 patients has revealed distinct subphenotypes…
View more
Added:
2 weeks ago
Dr Milton Packer (Baylor University Medical Center, Dallas, TX, US) joins us for a wide-ranging discussion on the conceptual foundations of heart failure, challenging several long-held assumptions about its mechanisms, classification and therapeutic targets, and considering what the field may still be getting wrong.In this interview, Dr Packer sets out why he believes some core ideas in heart…
View more
Added:
1 year ago
ACC 25 - Findings of the MIGHTy-Heart study shows no difference between mobile integrated healthcare and a traditional transitions of care coordinator approach in 30-day all-cause readmissions or health status.Dr Ruth Masterson Creber (Columbia University, New York, US) joins us onsite at ACC to discuss the findings from MIGHTy-Heart, a comparative effectiveness study that evaluated two different…
View more
Added:
2 weeks ago
Prof Debasish Banerjee (St George's University Hospitals NHS Foundation Trust, London, UK) joins us to discuss the practical management of heart failure in patients with coexisting chronic kidney disease (CKD) and diabetes, and how to close the gap between guideline recommendations and everyday clinical practice.In this interview, Prof Banerjee addresses one of the central challenges in cardio…
View more
Added:
2 weeks ago
Dr Stephen J Greene (Duke University School of Medicine, Durham, NC, US) joins us to discuss the practical realities of delivering guideline-directed medical therapy (GDMT) in heart failure, and how clinicians and programmes can move more patients towards near-optimal treatment despite the constraints of everyday practice.In this interview, Dr Greene addresses the persistent gap between what…
View more